ANI Pharmaceuticals Inc — Cash Flow (NASDAQ:ANIP) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Cash from operating activities 15.27 M3.32 M-31.2 M118.96 M64.02 M185.22 M 185.22 M Cash from investing activities -68.32 M-105.48 M-15.74 M-18.51 M-404.72 M34.32 M -31.52 M Cash from financing activities -1.44 M194.59 M-5.13 M67.44 M264.94 M9.94 M -672 K Free cash flow -53.05 M-20.32 M-47.66 M100.45 M47.06 M150.9 M 150.9 M

Nachrichten

RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus

PBYI Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 2026 View

TGTX Q4 Earnings Lag Estimates, Briumvi Sales Drive Top Line

PRGO Q4 Earnings Miss, Sales Beat, Stock Down on Weak 2026 View

ANI Pharma steigert Umsatz um 44 % durch Fokus auf seltene Krankheiten

ANI Pharma Q4 2025 slides: rare disease shift drives 44% revenue growth

ANI Pharma: EPS übertrifft Schätzungen um 0,36 $ - Umsatz besser als erwartet

ANI Pharma earnings beat by $0.36, revenue topped estimates

ANI Pharmaceuticals Turns Profit, Rare Disease Sales Surge 50% - ANI Pharmaceuticals (NASDAQ:ANIP)

Brightspring Health Services, BASF, Swiss Re and more set to report Friday

Viatris Q4 EPS Tops, Brands Drive Revenue Growth, Stock Up

ANI Pharmaceuticals set to report earnings as Cortrophin drives shift